TETANEA

Medicinal product

(Invented) name

TETANEA

Active substance (s)

Arklių imunoglobulino nuo stabligės F(ab')2 fragmentai

Strength

1500 TV/ml

Pharmaceutical form

injekcinis tirpalas užpildytame švirkšte

Route (s) of administration

leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J06BB02, Tetanus immunoglobulin

Marketing authorisation holder

Sanofi Pasteur, Prancūzija

Date of authorisation

2003-07-02

Date of renewal

2013-12-31

Documents

3487_1 TETANEA svirkste RPP 171031.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

1 ml tirpalo yra	1 ml
Arklių imunoglobulino nuo stabligės F(ab')2 fragmentai	1500 TV

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
6497	11583	1011583	užpildytas švirkštas	1 ml N1		Receptinis	LT/1/03/3487/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2019-12-27	Išregistruotas
2013-12-31	Perregistruotas
2003-07-02	Registruotas